Seeking Alpha

VPHM
ViroPharma Incorporated

5/26/2012, 12:35 PM ET
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
VPHM Market Currents more »
  • May 1 Weaker-than-expected Q1 results weigh on shares of ViroPharma (VPHM -9.5%), which has already dropped nearly 30% in the past month as what has been the drug devloper’s biggest seller, Vancocin, faces potential generic competition. Citing the generic threat, VPHM cuts its 2012 revenue target by nearly 25%. [Healthcare, On the Move]
VPHM News more »
VPHM Instablog posts more »
  • Magic Formula Investing Weekly Roundup 3/18/2012
    Sun, Mar 18 MagicDiligence Comment!
  • Magic Formula Investing Weekly Roundup 3/4/2012
    Sun, Mar 4 MagicDiligence Comment!
  • Magic Formula Investing Weekly Roundup 1/22/2012
    Sun, Jan 22 MagicDiligence Comment!
  • Weekly Homework: The Bond Market Holds The Truth (w/ Economic Calendar & Stock Radar)
    Sun, Jan 8 Michael Kudrna Comment!
  • 7 Notable Insider Purchases
    Tue, Dec 27, 2011 Insightful Investor Comment!
Write a post on VPHM
VPHM StockTalks
VPHM vs. ETF Alternatives
Company Description

ViroPharma Incorporated and subsidiaries is a global biotechnology company dedicated to the development and commercialization of products that address serious diseases, with a focus on products used by physician specialists or in hospital settings. We have two marketed products and two... More

Sector: Healthcare
Industry: Biotechnology
Country: United States